Xenon Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
XENE Nasdaq 2836 www.xenon-pharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Xenon Pharmaceuticals Inc.

RBC Raises Xenon Price Target, Cites Phase III Optimism for Epilepsy Drug - Jul 2nd, 2025 1:20 am
Xenon Joins the Russell 3000® and Russell 2000® Indexes - Jun 27th, 2025 2:01 pm
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jun 26th, 2025 2:01 pm
Xenon Announces Appointment of Darren Cline as Chief Commercial Officer - Jun 24th, 2025 6:30 am
Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue? - Jun 11th, 2025 9:30 am
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - Jun 3rd, 2025 2:01 pm
Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference - May 14th, 2025 2:01 pm
Why Xenon Pharmaceuticals Inc. (XENE) Declined on Tuesday - May 14th, 2025 6:18 am
Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus - May 13th, 2025 10:07 am
Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Call Highlights: Strong Financial Position ... - May 13th, 2025 1:09 am
Xenon Pharmaceuticals: Q1 Earnings Snapshot - May 12th, 2025 2:10 pm
Xenon Reports First Quarter 2025 Financial Results and Provides Business Update - May 12th, 2025 2:01 pm
Xenon to Report Q1 2025 Financial Results on May 12, 2025 - May 5th, 2025 2:01 pm
Wall Street Analysts See a 48.15% Upside in Xenon Pharmaceuticals (XENE): Can the Stock Really Move This High? - May 5th, 2025 7:55 am
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025 - Apr 4th, 2025 6:30 am
Xenon to Present at Stifel 2025 Virtual CNS Forum - Mar 12th, 2025 2:01 pm
Xenon Q4 Loss Narrower Than Expected, Pipeline Development in Focus - Feb 28th, 2025 7:36 am
Xenon Pharmaceuticals Inc (XENE) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... - Feb 28th, 2025 12:36 am
Xenon Pharmaceuticals: Q4 Earnings Snapshot - Feb 27th, 2025 2:18 pm
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update - Feb 27th, 2025 2:01 pm